Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug. This was particularly evident among MS patients who took beta interferon for more than three years.


https://www.sciencedaily.com/releases/2019/03/190318132638.htm

More Posts

Tilbud til Scleroseramte

6 timer taleFri sms/mms6GB data per månedKun 80,- per måned Igennem den aftale Sclerose.info har indgået med Evercall har du som scleroseramt eller pårrørende mulighed

Telefoni til medlemmer af Sclerose.info

Spændende samarbejde for Sclerose.info Sclerose.info har indgået samarbejde med teleselskabet evercall – som er et telefonfirma som mange sikkert kender igennem deres antenneforening. Det betyder,